Asian Pacific Journal of Allergy and Immunology

  • HOME
  • ABOUT
  • EDITORS
  • SUBMISSION
    • Online Submission
    • Author Instructions
  • ISSUE
    • Current
    • Early Online
    • Archives
  • PERMISSIONS
  • CONTACT
  • ADVERTISE
Home
 / 
Early Online
 / 
Incidence, predictors, and treatment outcomes of biphasicanaphylaxis in the emergency department of a tertiary hospital: A 5-year retrospective study

April 8, 2024
Early Online, Original Article

Incidence, predictors, and treatment outcomes of biphasicanaphylaxis in the emergency department of a tertiary hospital: A 5-year retrospective study

Waratchaya Uawattanasakul,1 Ploylarp Lertvipapath,2* Thanachit Krikeerati,3,4* Chamard Wongsa,3,4
Torpong Thongngarm,3,4 Mongkhon Sompornrattanaphan3,4

Affiliations:
1 Inpatient Pharmacy Division, Department of Pharmacy, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand
2 Adverse Drug Reaction Unit, Division of Academic Affairs, Department of Pharmacy, Siriraj Hospital, Mahidol University, Bangkok, Thailand
3 Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
4 Faculty of Medicine Siriraj Hospital, Center of Research Excellence in Allergy and Immunology, Mahidol University, Bangkok, Thailand, certified by the WAO Centers of Excellence (COE)

*These authors are an essentially intellectual contributors (EIC) of this work.

Abstract

Background: Biphasic anaphylaxis despite successful treatment has an incidence of 4-5% based on NIAID/FAAN criteria. Our study aimed to investigate the frequency and predictive factors associated with biphasic reactions within the emergency department (ED) at Siriraj Hospital.
Methods: This observational study assessed medical records of anaphylaxis and anaphylactic shock patients at Siriraj Hospital’s ED from January 2015 to December 2019. Of these, a random sample was reviewed and validated by allergists. Telephone interviews were performed to collect more data. Uni- or biphasic response were analyzed descriptively. Prediction modeling was performed.
Results: Among 1888 ED anaphylaxis cases, 601 were randomly sampled; 239 patients completing interviews were analyzed. The incidence of biphasic reactions was 7.1% (17/239) of cases. Common triggers of biphasic responses were foods (57.7%), drugs (31%), other known allergens (5.9%). Shellfish, edible insects, and wheat were the leading food triggers. Biphasic responses were significantly associated with history of drug allergy, any allergic disease, allergic rhinitis, number of prior anaphylactic reactions, angioedema, less generalized erythema, less reaction to shellfish, reaction to NSAIDs, and no epinephrine giving at ED visit (all p < 0.1). From a 3-predictor prognostic model including drug/idiopathic reaction, duration from onset to first epinephrine > 60 minutes, and any cutaneous edema/angioedema with an area under the curve of 0.72 (95%CI 0.54, 0.90).
Conclusions: The incidence of biphasic response was 7.1%. Predictors of biphasic response were drug/idiopathic reaction, any cutaneous edema/angioedema, and time from onset to first epinephrine > 60 minutes.
Key words: Anaphylaxis, Asia-Pacific, Biphasic anaphylaxis, Drug allergy, Emergency department, Food allergy, Prevalence, Risk factors

Full Text
Anaphylaxis, Asia-Pacific, Biphasic anaphylaxis, drug allergy, Emergency department, food allergy, prevalence, risk factors

Categories

  • Announcement (1)
  • Case Report (23)
  • Early Online (93)
  • Original Article (223)
  • Review Article (29)

Key words

allergen Allergic rhinitis Allergy Anaphylaxis Asthma atopic dermatitis child Children Chlorhexidine chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 cytokine depression diagnosis drug allergy Drug hypersensitivity efficacy Epidemiology food allergy Food hypersensitivity house dust mite IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine Vitamin D
Asian Pacific Journal of Allergy and Immunology

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org

Asian Pacific Journal of Allergy and Immunology © 2025 All rights reserved.
All rights reserved | Privacy Policy